RESULTS	In stable angina patients , 1-month MACE were not significantly different ( 7.0 vs. 3.9 % ; OR 1.84 , 0.60-5 .88 ; P = 0.36 ) , whereas ACS patients had significant clinical benefit with reloading ( 6.4 vs. 16.3 % ; OR 0.34 , 95 % CI 0.32-0 .90 , P = 0.033 at multivariable analysis ; interaction test : P = 0.01 ) .\